摘要:
The present invention describes the design and development of new fibrinogen and fibrinogen derived products with significantly reduced binding to bacteria while retaining normal physiological functions by using modified fibrinogen amino acid sequences. The present invention describes modified sequences of Fg ?-chains and ß-chains with reduced binding to S.aureus ClfA and S.epidermidis SdrG respectively. Modified Fg with the described modifications will not bind other bacterial surface proteins that bind Fg using similar mechanisms as ClfA and SdrG. These new Fg and Fg derived products will therefore have less binding to bacteria and will be advantageous compared to normal human Fg in a number of different settings.
摘要:
A method and device to deliver medication in a liquid, gel or suspension formulation to a plurality of adjacent tissue sites of a mammal, the device comprising a plurality of tissue- engaging members for receiving the medication and operably engageable with the plurality of tissue sites; means for supplying the tissue-engaging members with the formulation, and to temporarily sustain and control the rate of therapeutic agent/unit of time and preferably to sustain these controlled delivery rates over extended periods of time to enhance the local therapeutic effect of these therapeutic agents and to reduce the systemic toxicity and reduce unwanted side effects.
摘要:
The invention relates to a container for a liquid material to be supplied to a body, which container is provided with an outlet opening for the liquid material, wherein the container is provided with a heating device for heating the content of the container, wherein the heating device comprises a heating chamber coupled thermally to the interior of the container, and a substance is present in the heating chamber which, following initiation, produces an exothermic reaction. As a result of these measures the above stated drawbacks are avoided, since there is no longer a conductor present in or on the outer wall of the container. The heating chamber is preferably provided with a substance which, in the case of a mechanical shock, produces an exothermic physical reaction such as a phase transition or precipitation.
摘要:
Effective treatments of pain are provided. Through the administration of a drug depot containing an effective amount of a pain reliever near a target site, one can diagnose the location of the pain generator. In some embodiments, through the administration of a drug depot containing an effective amount of a pain reliever near a target site, one can prevent surgery at an incorrect anatomical location.
摘要:
The present invention provides a compound of formula I: wherein X - , R 1 , and R 2 are as defined herein, and compositions thereof. The compounds are peripheral opioid receptors.
摘要:
A trigger operated syringe (100) for intramammary injection of antibiotics has a fluid containing syringe cartridge (203) activated by a plunger (206) which is inserted into the syringe cartridge (203A) and expels fluid when the trigger (205) is pulled. A syringe cartridge holding mechanism (223) holds the syringe cartridge in place until the trigger (205) is released and the plunger (206) retracted. Single syringe cartridge (203) and multiple syringe cartridge (204) versions are disclosed. The plunger moves in a direction which is effectively perpendicular to the direction of movement of the trigger, allowing for ease of injection to a cow's teats, and ejection of the spent cartridges.
摘要:
A container for a product uses a location circuit for determining the location of the container, a storage element for storing a container identification code, a plurality of data acquisition components for acquiring status of at least two characteristics of at least one of the container, the product and a user of the product, and a communication interface for generating and sending a communication signal including (a) the container identification code from the storage element, (b) the location of the container from the location circuit, and (c) the status of the at least two characteristics from the data acquisition components. The container may be an auto-injector for containing a medicament, or a case for containing an item such as an auto-injector. Generally, the location circuit uses the global positioning system (GPS). The data acquisition components are chosen from a camera, and at least one sensor for sensing at least one of a thermal image, vibration, temperature, humidity, a chemical and an audio signal. The characteristic may be use of the product, or lack of use of at least one of the container and the product.
摘要:
A method for treating an osteochondral defect or a chondral defect in a subject includes implanting a composite in a site of the osteochondral or chondral defect. The composite includes a hyaluronic acid derivative; and at least one member of the group consisting of a cell, a cellular growth factor and a cellular differentiation factor, which is impregnated in, or coupled to, the hyaluronic acid derivative. In one embodiment, carboxyl functionalities of the hyaluronic acid derivative are. each independently derivatized to include an N-acylurea or O-acyl isourea, or both N-acylurea and O-acyl isourea. In another embodiment, the hyaluronic acid derivative is prepared by reacting an uncrosslinked hyaluronic acid with a biscarbodimide in the presence of a pH buffer in a range of between about (4) and about (8). The composite can be used for regenerating or stimulating regeneration of meniscal tissues in a subject in need thereof.
摘要:
A syringe (10) includes a releasable lock means (30) for allowing discharge of a treated biological fluid sample to the patient in response to a release signal to the releasable lock means. The release signal is issued following a positive outcome from a verification process dependent upon temporal data from certain events in the collection, treatment and delivery of the biological fluid sample, and identity data of the patient and the syringe with the treated biological fluid.